++ Neuste Pressemitteilung von Coronado Industries +++ 30.05.2002***** - 500 Beiträge pro Seite
eröffnet am 31.05.02 13:58:16 von
neuester Beitrag 31.05.02 14:14:09 von
neuester Beitrag 31.05.02 14:14:09 von
Beiträge: 3
ID: 593.216
ID: 593.216
Aufrufe heute: 0
Gesamt: 154
Gesamt: 154
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| 20.04.24, 12:11 | 225 | |
| gestern 12:15 | 207 | |
| gestern 23:15 | 172 | |
| gestern 23:07 | 143 | |
| 06.03.17, 11:10 | 142 | |
| heute 01:20 | 127 | |
| vor 1 Stunde | 99 | |
| gestern 22:28 | 81 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.015,00 | -0,90 | 204 | |||
| 2. | 2. | 9,6900 | -33,06 | 190 | |||
| 3. | 3. | 162,13 | +12,06 | 146 | |||
| 4. | 4. | 0,1940 | +1,57 | 69 | |||
| 5. | 5. | 6,7090 | -2,94 | 32 | |||
| 6. | 6. | 0,0211 | -32,59 | 29 | |||
| 7. | 7. | 1,3500 | -0,74 | 29 | |||
| 8. | 8. | 56,40 | +1,26 | 26 |
Feedback
Hallo, kann mir mal jemand diese Pressemitteilung erklären ? Ich bin zwar einigermaßen der englischen Sprache mächtig, aber anscheinend verstehe ich sie nicht !
Thursday May 30, 5:11 pm Eastern Time
Press Release
SOURCE: Coronado Industries Inc.
Coronado Industries Announces Ciba Vision Elects Not to Exercise Option
FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--May 30, 2002--Coronado Industries Inc. (OTC BB: CDIK - News), a manufacturer of proprietary pneumatic devices for the effective treatment of glaucoma, was informed today by Ciba Vision (a subsidiary of Novartis Ophthalmics) that they will not be exercising their option agreement.
Coronado officers are presently negotiating with other parties to replace Novartis as a partner in the distribution of their patented PNT device.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company`s products, increased levels of competition for the company, new products and technological changes, the company`s dependence on third-party suppliers, and other risks detailed from time to time in the company`s periodic reports filed with the Securities and Exchange Commission.
--------------------------------------------------------------------------------
Contact:
Coronado Industries Inc., Fountain Hills
G. Richard Smith, 480/837-6810
Thursday May 30, 5:11 pm Eastern Time
Press Release
SOURCE: Coronado Industries Inc.
Coronado Industries Announces Ciba Vision Elects Not to Exercise Option
FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--May 30, 2002--Coronado Industries Inc. (OTC BB: CDIK - News), a manufacturer of proprietary pneumatic devices for the effective treatment of glaucoma, was informed today by Ciba Vision (a subsidiary of Novartis Ophthalmics) that they will not be exercising their option agreement.
Coronado officers are presently negotiating with other parties to replace Novartis as a partner in the distribution of their patented PNT device.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company`s products, increased levels of competition for the company, new products and technological changes, the company`s dependence on third-party suppliers, and other risks detailed from time to time in the company`s periodic reports filed with the Securities and Exchange Commission.
--------------------------------------------------------------------------------
Contact:
Coronado Industries Inc., Fountain Hills
G. Richard Smith, 480/837-6810
Ciba hat Coronado mitgeteilt, dass sie ihre Optionsrechte nicht wahrnehmen werden....
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 204 | ||
| 190 | ||
| 146 | ||
| 69 | ||
| 32 | ||
| 29 | ||
| 29 | ||
| 26 | ||
| 26 | ||
| 25 |
| Wertpapier | Beiträge | |
|---|---|---|
| 24 | ||
| 23 | ||
| 23 | ||
| 23 | ||
| 22 | ||
| 22 | ||
| 22 | ||
| 21 | ||
| 20 | ||
| 20 |
